Sana Biotechnology Inc (SANA) Stock Price, Quote & News

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 701 7914

Website: www.sana.com

Address:

188 East Blaine Street, Suite 400, Seattle, United States

BBraggHillBoys Aug. 25 at 8:11 PM

$SANA Bullish catalyst if Mayo exercises its option.

0 · Reply

BriOnH Aug. 25 at 6:43 PM

$SANA 6 more days, by or on Aug 31, is the deadline for Mayo to exercise their option to buy 25m more shares at $3.33. I think it's safe to assume Mayo will be running Sana's phase 1/2 trial, but were they expecting a milestone to be hit before Aug 31?

1 · Reply

BBraggHillBoys Aug. 25 at 3:41 PM

$SANA hanging here like a champ!

0 · Reply

PastaSlobCFA Aug. 25 at 2:34 PM

$SANA quick squeeze to $10.00 please!!

0 · Reply

ConsulHorkos Aug. 25 at 2:29 PM

$SANA nice pop today.

0 · Reply

LoveRetailFroth Aug. 25 at 2:10 PM

$RXRX Good Morning 💎 s☕️ $SANA $ARBE $AMLX

0 · Reply

LoveRetailFroth Aug. 24 at 1:58 PM

$RXRX Good SILLY Morning ☕️ $SANA $ARBE Stellar as usual is $AMLX as we make our way to $50 plus

0 · Reply

Cheesyisi Aug. 24 at 4:42 AM

$SANA

0 · Reply

LoveRetailFroth Aug. 22 at 2:41 PM

$AMLX Good Saturday Morning Folks☕️ I posted when I was down 15% last couple of weeks, so why not post when I am up😂 My portfolio grew an astonishing 30% last week finally achieving positive returns for the yr thanks to this 💎, $RXRX $SANA & $TEM $MRNA I see more crazy upside in all these next week. GL & have a great weekend!

0 · Reply

LoveRetailFroth Aug. 22 at 1:55 AM

$AMLX What week folks! $MRNA $RXRX $SANA Have a great weekend 🍺

1 · Reply

Sana Biotechnology price target lowered to $6 from $7 at BofA

2026-08-10T20:46:01.000Z - 15 days ago

Sana Biotechnology reports Q2 EPS (13c), consensus (12c)

Aug 10, 2026, 4:00 PM EDT - 15 days ago

Sana Biotechnology Earnings release: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 15 days ago

Sana Biotechnology Quarterly report: Q2 2026

Aug 10, 2026, 7:00 AM EDT - 15 days ago

Sana Biotechnology Slides: Corporate presentation

Jul 29, 2026, 10:09 AM EDT - 27 days ago

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

2026-07-13T13:30:18.000Z - 6 weeks ago

Sana Biotechnology announces publication of long-term diabetes data

Jul 13, 2026, 8:00 AM EDT - 6 weeks ago

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Jul 1, 2026, 9:00 AM EDT - 7 weeks ago

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Jun 9, 2026, 4:00 PM EDT - 2 months ago

Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 3, 2026, 9:20 AM EDT - 2 months ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology to Present at June 2026 Investor Conferences

May 15, 2026, 9:00 AM EDT - 3 months ago

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

2026-05-12T22:28:22.000Z - 3 months ago

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

May 12, 2026, 5:20 PM EDT - 3 months ago

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

2026-05-11T20:42:28.000Z - 3 months ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

May 11, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Sana Biotechnology Slides: Corporate presentation

2026-05-11T17:02:47.000Z - 3 months ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

May 5, 2026, 4:05 PM EDT - 4 months ago

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Apr 27, 2026, 4:30 PM EDT - 4 months ago

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Sana Biotechnology Proxy statement: Proxy filing

2026-04-14T13:23:10.000Z - 4 months ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-13T20:18:08.000Z - 4 months ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Sana Biotechnology Slides: Corporate presentation

2026-03-13T13:10:51.000Z - 5 months ago

Sana announces follow-up results from first-in-human study transplanting UP421

Mar 11, 2026, 1:40 PM EDT - 5 months ago

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

2026-03-03T22:25:38.000Z - 6 months ago

Sana Biotechnology files automatic mixed securities shelf

2026-03-03T21:25:24.000Z - 6 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

Mar 3, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Annual report: Q4 2025

Mar 3, 2026, 3:00 PM EST - 6 months ago

Sana Biotechnology Earnings release: Q4 2025

Mar 2, 2026, 1:10 PM EST - 6 months ago

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 4:05 PM EST - 6 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences

2026-02-17T14:16:15.000Z - 6 months ago

Sana Biotechnology appoints Piper as EVP, CFO

Jan 14, 2026, 12:45 PM EST - 7 months ago

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:00 PM EST - 7 months ago

Sana Biotechnology Slides: Corporate presentation

Jan 7, 2026, 4:26 PM EST - 8 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

2026-01-06T15:25:24.000Z - 8 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA

2025-12-08T14:05:59.000Z - 9 months ago

Sana Biotechnology announces publication of in vivo gene editing

Dec 8, 2025, 9:00 AM EST - 9 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 3, 2025, 2:35 PM EST - 9 months ago

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 2, 2025, 2:30 PM EST - 9 months ago

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Nov 24, 2025, 4:05 PM EST - 9 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 12, 2025, 1:30 PM EST - 10 months ago

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

2025-11-06T23:25:54.000Z - 10 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Sana Biotechnology Quarterly report: Q3 2025

Nov 5, 2025, 6:00 PM EST - 10 months ago

Sana Biotechnology Slides: Investor Presentation

2025-10-30T10:25:41.000Z - 10 months ago

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

2025-10-15T17:45:20.000Z - 11 months ago

Sana Biotechnology strength attributed to EMJ Capital long call

2025-09-24T11:45:09.000Z - 11 months ago

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

Sep 9, 2025, 9:30 AM EDT - 1 year ago

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 11:30 AM EDT - 1 year ago

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 2, 2025, 3:15 PM EDT - 1 year ago

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

Aug 28, 2025, 8:00 AM EDT - 1 year ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Aug 26, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 20, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q2 2025

Aug 6, 2025, 11:24 PM EDT - 1 year ago

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 4:38 PM EDT - 1 year ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Aug 4, 2025, 11:35 AM EDT - 1 year ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Jun 23, 2025, 10:05 AM EDT - 1 year ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 10, 2025, 8:40 AM EDT - 1 year ago

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 4, 2025, 2:35 PM EDT - 1 year ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Sana Biotechnology Slides: Corporate Presentation

May 28, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at June 2025 Investor Conferences

May 13, 2025, 12:20 PM EDT - 1 year ago

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 8, 2025, 4:00 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q1 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Sana Biotechnology Proxy statement: Proxy Filing

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Sana Biotechnology Annual report: Q4 2024

Mar 17, 2025, 5:00 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q4 2024

Mar 17, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

BBraggHillBoys Aug. 25 at 8:11 PM

$SANA Bullish catalyst if Mayo exercises its option.

0 · Reply

BriOnH Aug. 25 at 6:43 PM

1 · Reply

BBraggHillBoys Aug. 25 at 3:41 PM

$SANA hanging here like a champ!

0 · Reply

PastaSlobCFA Aug. 25 at 2:34 PM

$SANA quick squeeze to $10.00 please!!

0 · Reply

ConsulHorkos Aug. 25 at 2:29 PM

$SANA nice pop today.

0 · Reply

LoveRetailFroth Aug. 25 at 2:10 PM

$RXRX Good Morning 💎 s☕️ $SANA $ARBE $AMLX

0 · Reply

LoveRetailFroth Aug. 24 at 1:58 PM

$RXRX Good SILLY Morning ☕️ $SANA $ARBE Stellar as usual is $AMLX as we make our way to $50 plus

0 · Reply

Cheesyisi Aug. 24 at 4:42 AM

$SANA

0 · Reply

LoveRetailFroth Aug. 22 at 2:41 PM

0 · Reply

LoveRetailFroth Aug. 22 at 1:55 AM

$AMLX What week folks! $MRNA $RXRX $SANA Have a great weekend 🍺

1 · Reply

LoveRetailFroth Aug. 21 at 10:24 PM

$MRNA Hoe are the bears feeling?😂🍺 $AMLX $RXRX $SANA

0 · Reply

LoveRetailFroth Aug. 21 at 6:31 PM

$RXRX $SANA Was busy with a small psychedelic $JUNS all morning 🍺

0 · Reply

Trigga_tha_Gambler Aug. 21 at 6:15 PM

$SANA Lol. Traders taking losses, selling near intraday lows.

0 · Reply

LoveRetailFroth Aug. 21 at 2:02 PM

$RXRX 37% SHORT!!! Fuck them $8 🚀🚀💎 $SANA

0 · Reply

LoveRetailFroth Aug. 21 at 1:59 PM

$MRNA Yeah 🚀 Folks look @ $RXRX $SANA Go🚀🚀

0 · Reply

LoveRetailFroth Aug. 21 at 1:29 PM

$MRNA Good Morning my bio💎 s $AMLX $RXRX $SANA

0 · Reply

Merlintrader Aug. 20 at 9:03 PM

$SANA Cash and securities rose to 160.5 million dollars at June 30 from 138.4 million at year-end, funding two lead programmes in type 1 diabetes and in vivo CAR T. The 10-Q filed August 10 also states substantial doubt about going concern, so the financing path stays part of the story. Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/sana-biotechnology-sana-stock-hub/?utm_source=stocktwits&utm_medium=social&utm_campaign=moderna-20ago2026

0 · Reply